|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$0.50 |
$0.52 |
$0.50 |
$0.51 |
365.40K | 03/22/2024 |
$0.51 |
$0.51 |
$0.48 |
$0.48 |
500.60K | 03/25/2024 |
$0.48 |
$0.49 |
$0.45 |
$0.46 |
713.80K | 03/26/2024 |
$0.46 |
$0.48 |
$0.46 |
$0.48 |
292.80K | 03/27/2024 |
$0.48 |
$0.53 |
$0.48 |
$0.51 |
463.20K |
|
RedHill Biopharma is a biopharmaceutical company that focuses on commercialization and development of proprietary drugs for gastrointestinal (GI) diseases. The ongoing development programs of Co.'s therapeutic candidates, most in late-stage clinical development, include: RHB-204, which is for the treatment of mycobacterium avium complex disease; RHB-104, which is an investigational drug intended to treat Crohn's disease; RHB-102 (Bekinda®), which is an investigational once-daily bi-modal extended-release oral formulation of ondansetron; and RHB-106, which is an investigational tablet intended for the preparation and cleansing of the GI tract prior to the performance of abdominal procedures. | |
|
Redhill Biopharma Ltd Ramat Gan (RDHL) has the following price history information. Looking back at RDHL historical stock prices for the last five trading days, on March 21, 2024, RDHL opened at $0.50, traded as high as $0.52 and as low as $0.50, and closed at $0.51. Trading volume was a total of 365.40K shares. On March 22, 2024, RDHL opened at $0.51, traded as high as $0.51 and as low as $0.48, and closed at $0.48. Trading volume was a total of 500.60K shares. On March 25, 2024, RDHL opened at $0.48, traded as high as $0.49 and as low as $0.45, and closed at $0.46. Trading volume was a total of 713.80K shares. On March 26, 2024, RDHL opened at $0.46, traded as high as $0.48 and as low as $0.46, and closed at $0.48. Trading volume was a total of 292.80K shares. On March 27, 2024, RDHL opened at $0.48, traded as high as $0.53 and as low as $0.48, and closed at $0.51. Trading volume was a total of 463.20K shares.
RDHL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Redhill Biopharma Ltd Ramat Gan shares, starting with a $10,000 purchase of RDHL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$563.60 |
|
End price/share: |
$0.51 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.91% |
|
Average Annual Total Return: |
-50.37% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9.08 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $0.51 | 03/22/2024 | $0.48 | 03/25/2024 | $0.46 | 03/26/2024 | $0.48 | 03/27/2024 | $0.51 |
|
|